{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:42:29Z","timestamp":1788349349219,"version":"build-2803163510"},"reference-count":127,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institutes of Health Early Independence","award":["DP5OD019892"],"award-info":[{"award-number":["DP5OD019892"]}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","award":["R01HL13557501"],"award-info":[{"award-number":["R01HL13557501"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","award":["P01HL132819"],"award-info":[{"award-number":["P01HL132819"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion Medicine Reviews"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.tmrv.2019.09.006","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T12:09:16Z","timestamp":1571400556000},"page":"217-224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions"],"prefix":"10.1016","volume":"33","author":[{"given":"Connie M.","family":"Arthur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satheesh","family":"Chonat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Fasano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne E.M.","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra D.","family":"Josephson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Roback","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean R.","family":"Stowell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmrv.2019.09.006_bb0005","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1046\/j.1537-2995.1990.30490273445.x","article-title":"The first recorded blood transfusions: 1656 to 1668","volume":"30","author":"Myhre","year":"1990","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0010","first-page":"471","article-title":"Blood transfusion from antiquity to the discovery of the Rh factor","volume":"33","author":"Hajdu","year":"2003","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0015","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2003.04295.x","article-title":"Karl Landsteiner and his major contributions to haematology","volume":"121","author":"Schwarz","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0020","first-page":"357","volume":"27","author":"Landsteiner","year":"1900","journal-title":"Zentbl Bakt Parasitkde (Abt)"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0025","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1084\/jem.13.4.425","article-title":"Studies in isoagglutination: I. transfusion and the question of intravascular agglutination","volume":"13","author":"Ottenberg","year":"1911","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0030","series-title":"Biologic roles of the ABH and Lewis histo-blood group antigens part II: Thrombosis, cardiovascular disease and metabolism, Vox Sang","author":"Stowell","year":"2019"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0035","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/vox.12787","article-title":"Biologic roles of the ABH and Lewis histo-blood group antigens part I: infection and immunity","volume":"114","author":"Stowell","year":"2019","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0040","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/jama.1939.72800270002007a","article-title":"An unusual case of intra-group agglutination","volume":"113","author":"Levine","year":"1939","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3181\/00379727-43-11151","article-title":"An agglutinable factor in human blood recognized by immune sera in rhesus blood","volume":"43","author":"Landsteiner","year":"1940","journal-title":"Proc Soc Exp Biol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0050","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.7326\/0003-4819-13-12-2306","article-title":"Hemolytic reactions following transfusions of blood of the homologous group, with three cases in which the same agglutinogen was responsible","volume":"12","author":"Weiner","year":"1940","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0055","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1046\/j.1423-0410.1998.7420067.x","article-title":"Historical note: past, present and future of the antiglobulin test","volume":"74","author":"Coombs","year":"1998","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0060","first-page":"518","article-title":"Transfusion errors: scope of the problem, consequences","volume":"2","author":"Sazama","year":"2003","journal-title":"and solutions, Curr Hematol Rep"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0065","doi-asserted-by":"crossref","unstructured":"K. Sazama. Reports of 355 transfusion-associated deaths: 1976 through 1985, Transfusion 1990; 30:583\u2013590.","DOI":"10.1046\/j.1537-2995.1990.30790385515.x"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0070","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1309\/VXY1ULAFUY6E6JT3","article-title":"Clinical outcomes of ABO-incompatible RBC transfusions","volume":"129","author":"Janatpour","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/00313028909061055","article-title":"ABO incompatible blood transfusion","volume":"21","author":"Bacon","year":"1989","journal-title":"Pathology"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0080","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.transci.2006.05.007","article-title":"Xenotransplantation and ABO incompatible transplantation: the similarities they share","volume":"35","author":"Galili","year":"2006","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0085","doi-asserted-by":"crossref","first-page":"6007","DOI":"10.1182\/blood-2010-10-315473","article-title":"Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis","volume":"117","author":"Smith","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0090","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/bjh.12061","article-title":"Challenges of alloimmunization in patients with haemoglobinopathies","volume":"159","author":"Chou","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0095","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1182\/blood-2011-11-327361","article-title":"Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management","volume":"120","author":"Yazdanbakhsh","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0100","doi-asserted-by":"crossref","first-page":"48","DOI":"10.21307\/immunohematology-2019-231","article-title":"The ABO blood group system revisited: a review and update","volume":"25","author":"Storry","year":"2009","journal-title":"Immunohematology"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0105","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/trf.14775","article-title":"Current state of transfusion practices for ABO-incompatible pediatric heart transplant patients in the United States and Canada","volume":"58","author":"Dean","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0110","doi-asserted-by":"crossref","unstructured":"C.D. Josephson, M.I. Castillejo, K. Grima, C.D. Hillyer. ABO-mismatched platelet transfusions: strategies to mitigate patient exposure to naturally occurring hemolytic antibodies, Transfus Apher Sci 42:83\u201388.","DOI":"10.1016\/j.transci.2009.10.013"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0115","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1537-2995.2004.03290.x","article-title":"Significant numbers of apheresis-derived group O platelet units have \u201chigh-titer\u201d anti-A\/A,B: implications for transfusion policy","volume":"44","author":"Josephson","year":"2004","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0120","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jpeds.2010.05.024","article-title":"Hemolysis and hyperbilirubinemia in antiglobulin positive, direct ABO blood group heterospecific neonates","volume":"157","author":"Kaplan","year":"2010","journal-title":"J Pediatr"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0125","first-page":"349","article-title":"Rapid clearance of Rh positive blood during experimental Rh immunisation","volume":"17","author":"Woodrow","year":"1969","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0130","first-page":"349","article-title":"Effect on primary Rh immunization of delayed administration of anti-Rh","volume":"28","author":"Samson","year":"1975","journal-title":"Immunology"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0135","first-page":"1073","article-title":"A critical study of the IgG subclasses of Rh anti-D antibodies formed in pregnancy and in immunized volunteers","volume":"27","author":"Devey","year":"1974","journal-title":"Immunology"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0140","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.173.4.1025","article-title":"The differential ability of human IgG1 and IgG4 to activate complement is determined by the COOH-terminal sequence of the CH2 domain","volume":"173","author":"Tao","year":"1991","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0145","doi-asserted-by":"crossref","first-page":"3393","DOI":"10.4049\/jimmunol.160.7.3393","article-title":"Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells","volume":"160","author":"Wright","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nm0395-237","article-title":"Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein","volume":"1","author":"Malhotra","year":"1995","journal-title":"Nat Med"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0155","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1182\/blood-2013-09-527978","article-title":"A prominent lack of IgG1-fc fucosylation of platelet alloantibodies in pregnancy","volume":"123","author":"Kapur","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0160","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1111\/trf.14923","article-title":"Stability of anti-A blood group titers among blood group B renal transplant candidates","volume":"58","author":"Jacob","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0165","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1182\/blood-2018-02-785964","article-title":"How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions","volume":"131","author":"Pirenne","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0170","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.13494","article-title":"How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease","volume":"170","author":"Gardner","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0175","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1182\/blood-2009-06-227793","article-title":"Immunogenicity of blood group antigens: a mathematical model corrected for antibody evanescence with exclusion of naturally occurring and pregnancy-related antibodies","volume":"114","author":"Tormey","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0180","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/trf.13611","article-title":"Anti-HI can cause a severe delayed hemolytic transfusion reaction with hyperhemolysis in sickle cell disease patients","volume":"56","author":"Ibanez","year":"2016","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.tmrv.2019.09.006_bb0185","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/trf.15010","article-title":"Multiple hemolytic transfusion reactions misinterpreted as severe vaso-occlusive crisis in a patient with sickle cell disease","volume":"59","author":"Dean","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0190","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1002\/ajh.24908","article-title":"Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease","volume":"92","author":"Narbey","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0195","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/ajh.24460","article-title":"Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes","volume":"91","author":"Habibi","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0200","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/bjh.13339","article-title":"Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience","volume":"169","author":"Vidler","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0205","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ajh.24537","article-title":"A diagnostic nomogram for delayed hemolytic transfusion reaction in sickle cell disease","volume":"91","author":"Mekontso Dessap","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0210","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM200104123441506","article-title":"Complement. Second of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0215","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1056\/NEJM200104053441406","article-title":"Complement. First of two parts","volume":"344","author":"Walport","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01893019","article-title":"The alternative pathway of complement","volume":"7","author":"Pangburn","year":"1984","journal-title":"Springer Semin Immunopathol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0225","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nri800","article-title":"Evolution of the lectin-complement pathway and its role in innate immunity","volume":"2","author":"Fujita","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0230","series-title":"Nat Rev Immunol","article-title":"New insights into the immune functions of complement","author":"Reis","year":"2019"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0235","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0167-5699(88)91240-6","article-title":"The multifunctional role of C3, the third component of complement","volume":"9","author":"Lambris","year":"1988","journal-title":"Immunol Today"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cell.2006.01.046","article-title":"A dominant complement fixation pathway for pneumococcal polysaccharides initiated by SIGN-R1 interacting with C1q","volume":"125","author":"Kang","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0245","doi-asserted-by":"crossref","first-page":"16879","DOI":"10.1073\/pnas.0406678101","article-title":"Activation of the complement system generates antibacterial peptides","volume":"101","author":"Nordahl","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0250","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nm1753","article-title":"Functional roles for C5a receptors in sepsis","volume":"14","author":"Rittirsch","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0255","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00109-009-0442-7","article-title":"Functions of C5a receptors","volume":"87","author":"Ward","year":"2009","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0260","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1042\/bj1930115","article-title":"The covalent-binding reaction of complement component C3","volume":"193","author":"Sim","year":"1981","journal-title":"Biochem J"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0152337","article-title":"Quantitative modeling of the alternative pathway of the complement system","volume":"11","author":"Zewde","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0270","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0162-3109(99)00157-5","article-title":"Critical role of Kupffer cell CR3 (CD11b\/CD18) in the clearance of IgM-opsonized erythrocytes or soluble beta-glucan","volume":"46","author":"Yan","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0275","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.cell.2005.12.039","article-title":"CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens","volume":"124","author":"Helmy","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0280","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molimm.2008.09.026","article-title":"Complement receptor 1: disease associations and therapeutic implications","volume":"46","author":"Khera","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0285","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1083\/jcb.127.4.1139","article-title":"Complement receptor 3 (CR3, mac-1, integrin alpha M beta 2, CD11b\/CD18) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils","volume":"127","author":"Graham","year":"1994","journal-title":"J Cell Biol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0290","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S1074-7613(02)00328-X","article-title":"CR3 (CD11b\/CD18) and CR4 (CD11c\/CD18) are involved in complement-independent antibody-mediated phagocytosis of Cryptococcus neoformans","volume":"16","author":"Taborda","year":"2002","journal-title":"Immunity"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0295","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0952-7915(91)90081-B","article-title":"Complement receptors and phagocytosis","volume":"3","author":"Brown","year":"1991","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0300","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev.iy.04.040186.002443","article-title":"The membrane attack complex of complement","volume":"4","author":"Muller-Eberhard","year":"1986","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0305","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.imbio.2006.11.002","article-title":"Serine proteases of the classical and lectin pathways: similarities and differences","volume":"212","author":"Gal","year":"2007","journal-title":"Immunobiology"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0310","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-3083.1988.tb01471.x","article-title":"On the interaction of the first complement component C1 and its subunit C1q with solid-phase IgM immune complexes","volume":"28","author":"Weiner","year":"1988","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0315","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1128\/JVI.76.3.1369-1378.2002","article-title":"Complement component C1q enhances the biological activity of influenza virus hemagglutinin-specific antibodies depending on their fine antigen specificity and heavy-chain isotype","volume":"76","author":"Feng","year":"2002","journal-title":"J Virol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0320","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2249.1991.tb08115.x","article-title":"The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human fc regions","volume":"84","author":"Lucisano Valim","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0325","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1172\/JCI106847","article-title":"Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum","volume":"51","author":"Schreiber","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0330","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0161-5890(88)90076-4","article-title":"C1q binding by a high affinity anti-fluorescein murine monoclonal IgM antibody and monomeric subunits","volume":"25","author":"Swanson","year":"1988","journal-title":"Mol Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0335","doi-asserted-by":"crossref","first-page":"307093","DOI":"10.1155\/2012\/307093","article-title":"Initiation and regulation of complement during hemolytic transfusion reactions","volume":"2012","author":"Stowell","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0340","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1111\/j.1537-2995.2012.03647.x","article-title":"Biphasic clearance of incompatible red blood cells through a novel mechanism requiring neither complement nor Fcgamma receptors in a murine model","volume":"52","author":"Liepkalns","year":"2012","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0345","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1182\/blood-2013-06-508952","article-title":"A novel role for C3 in antibody-induced red blood cell clearance and antigen modulation","volume":"122","author":"Girard-Pierce","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0350","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2141.1958.tb03843.x","article-title":"Relation between characteristics of blood-group antibodies in vitro and associated patterns of redcell destruction in vivo","volume":"4","author":"Cutbush","year":"1958","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0355","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0021-9258(17)36104-5","article-title":"Novel blood group H glycolipid antigens exclusively expressed in blood group a and AB erythrocytes (type 3 chain H). II. Differential conversion of different H substrates by A1 and A2 enzymes, and type 3 chain H expression in relation to secretor status","volume":"261","author":"Clausen","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0360","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1537-2995.1982.22482251204.x","article-title":"Clinical significance of the anti-complement component of antiglobulin antisera","volume":"22","author":"Howard","year":"1982","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0365","first-page":"102","article-title":"An acute haemolytic transfusion reaction due to anti-Jk","volume":"5","author":"Villa","year":"2007","journal-title":"Blood transfusion = Trasfusione del sangue"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0370","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/trf.14452","article-title":"Anti-RhD reduces levels of detectable RhD antigen following anti-RhD infusion","volume":"58","author":"Sullivan","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0375","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1182\/blood-2016-11-749432","article-title":"Daratumumab (anti-CD38) induces loss of CD38 on red blood cells","volume":"129","author":"Sullivan","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0380","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1042\/bj2640581","article-title":"Functional properties of membrane cofactor protein of complement","volume":"264","author":"Seya","year":"1989","journal-title":"Biochem J"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0385","first-page":"7","article-title":"Decay accelerating factor (CD55)","volume":"178","author":"Nicholson-Weller","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0390","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V78.3.820.820","article-title":"Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum","volume":"78","author":"Wilcox","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0395","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.clim.2005.10.014","article-title":"Membrane complement regulatory proteins","volume":"118","author":"Kim","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0400","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.4049\/jimmunol.155.10.4955","article-title":"Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b","volume":"155","author":"Ollert","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0405","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1084\/jem.148.4.1044","article-title":"Human C4-binding protein. II. Role in proteolysis of C4b by C3b-inactivator","volume":"148","author":"Fujita","year":"1978","journal-title":"J Exp Med"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0410","first-page":"154","article-title":"The Kell system studied with radioactively-labelled anti-K","volume":"21","author":"Hughes-Jones","year":"1971","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0415","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/ars.2009.2822","article-title":"Heme degradation and vascular injury","volume":"12","author":"Belcher","year":"2010","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0420","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood.V98.6.1802","article-title":"Heme is a potent inducer of inflammation in mice and is counteracted by heme oxygenase","volume":"98","author":"Wagener","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0425","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9343(88)80092-5","article-title":"Thrombophlebitis and disturbed hemostasis following administration of intravenous hematin in normal volunteers","volume":"85","author":"Simionatto","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0430","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","article-title":"The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease","volume":"293","author":"Rother","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0435","doi-asserted-by":"crossref","unstructured":"J.H. Baek, F. D'Agnillo, F. Vallelian, C.P. Pereira, M.C. Williams, Y. Jia, D.J. Schaer, P.W. Buehler. Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in Guinea pigs by haptoglobin therapy, J Clin Invest 122:1444\u20131458.","DOI":"10.1172\/JCI59770"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0440","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1182\/blood.V12.9.834.834","article-title":"The nature of the hemorrhagic disorder accompanying hemolytic transfusion reactions in man","volume":"12","author":"Krevans","year":"1957","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0445","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1681\/ASN.2006080894","article-title":"Physiology and pathophysiology of heme: implications for kidney disease","volume":"18","author":"Tracz","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0450","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1182\/blood-2008-01-132092","article-title":"Cytokine storm in a mouse model of IgG-mediated hemolytic transfusion reactions","volume":"112","author":"Hod","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0455","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.96910","article-title":"Intravascular hemolysis activates complement via cell-free heme and heme-loaded microvesicles","volume":"3","author":"Merle","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0460","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1182\/blood.V83.3.842.842","article-title":"Defective regulation of complement by the sickle erythrocyte: evidence for a defect in control of membrane attack complex formation","volume":"83","author":"Test","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0465","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1182\/blood-2015-09-669770","article-title":"Eculizumab salvage therapy for delayed hemolysis transfusion reaction in sickle cell disease patients","volume":"127","author":"Dumas","year":"2016","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.tmrv.2019.09.006_bb0470","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.3324\/haematol.2018.194670","article-title":"Contribution of alternative complement pathway to delayed hemolytic transfusion reaction in sickle cell disease","volume":"103","author":"Chonat","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0475","series-title":"Nat Rev Drug Discov","article-title":"Clinical promise of next-generation complement therapeutics","author":"Mastellos","year":"2019"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0480","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.tracli.2019.03.002","article-title":"Challenges in preventing and treating hemolytic complications associated with red blood cell transfusion","volume":"26","author":"Chonat","year":"2019","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0485","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1111\/j.1538-7836.2012.04705.x","article-title":"Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance","volume":"10","author":"Miller","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0490","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1537-2995.2012.03910.x","article-title":"Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion","volume":"53","author":"Liepkalns","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0495","doi-asserted-by":"crossref","first-page":"5013","DOI":"10.4049\/jimmunol.1300885","article-title":"Antigen modulation confers protection to red blood cells from antibody through Fcgamma receptor ligation","volume":"191","author":"Stowell","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0500","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1182\/blood-2007-04-083097","article-title":"Nonhemolytic antigen loss from red blood cells requires cooperative binding of multiple antibodies recognizing different epitopes","volume":"110","author":"Zimring","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0505","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2141.1984.tb01268.x","article-title":"In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes","volume":"56","author":"Branch","year":"1984","journal-title":"Br J Haematol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0510","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1046\/j.1537-2995.1981.21582040822.x","article-title":"The detection of clinically significant erythrocyte alloantibodies using a human mononuclear phagocyte assay","volume":"21","author":"Schanfield","year":"1981","journal-title":"Transfusion"},{"issue":"Suppl. 1","key":"10.1016\/j.tmrv.2019.09.006_bb0515","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1007\/s10875-014-0018-3","article-title":"Fc glycan-modulated immunoglobulin G effector functions","volume":"34","author":"Quast","year":"2014","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0520","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1111\/trf.13592","article-title":"Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay","volume":"56","author":"Cunnion","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0525","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/trf.13948","article-title":"Discriminating the hemolytic risk of blood type a plasmas using the complement hemolysis using human erythrocytes (CHUHE) assay","volume":"57","author":"Cunnion","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0530","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/trf.14030","article-title":"Toward functional assays for assessing the significance of anti-ABO(H) alloantibodies","volume":"57","author":"Stowell","year":"2017","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0535","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1537-2995.1983.23183147303.x","article-title":"A clinically significant erythrocyte antibody detectable only by 51Cr survival studies","volume":"23","author":"Baldwin","year":"1983","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0540","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.tmrv.2007.12.002","article-title":"Integrating molecular technologies for red blood cell typing and compatibility testing into blood centers and transfusion services","volume":"22","author":"Hillyer","year":"2008","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0545","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1182\/blood.V76.7.1431.1431","article-title":"Transfusion and alloimmunization in sickle cell disease. The cooperative Study of sickle cell disease","volume":"76","author":"Rosse","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0550","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJM199006073222301","article-title":"Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood","volume":"322","author":"Vichinsky","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0555","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1111\/trf.14282","article-title":"Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia","volume":"57","author":"Yee","year":"2017","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.tmrv.2019.09.006_bb0560","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1111\/trf.14610","article-title":"Hemoglobin a clearance in children with sickle cell anemia on chronic transfusion therapy","volume":"58","author":"Yee","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0565","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.3324\/haematol.2017.175752","article-title":"Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome","volume":"102","author":"Singhal","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0570","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/trf.13379","article-title":"Impact of red blood cell alloimmunization on sickle cell disease mortality: a case series","volume":"56","author":"Nickel","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0575","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/MOH.0b013e32833e5ac7","article-title":"Minority donation in the United States: challenges and needs","volume":"17","author":"Shaz","year":"2010","journal-title":"Curr Opin Hematol"},{"issue":"6","key":"10.1016\/j.tmrv.2019.09.006_bb0580","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1111\/trf.13037","article-title":"Barriers to using molecularly typed minority red blood cell donors in support of chronically transfused adult patients with sickle cell disease","volume":"55","author":"Karafin","year":"2015","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0585","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.3324\/haematol.2014.114561","article-title":"Treatment of autoimmune hemolytic anemias","volume":"99","author":"Zanella","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0590","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1182\/blood-2010-03-259325","article-title":"How I treat autoimmune hemolytic anemias in adults","volume":"116","author":"Lechner","year":"2010","journal-title":"Blood"},{"issue":"Suppl. 2","key":"10.1016\/j.tmrv.2019.09.006_bb0595","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1365-2036.1996.22164025.x","article-title":"Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies","volume":"10","author":"Brattsand","year":"1996","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0600","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1423-0410.1995.tb00373.x","article-title":"Post-transfusion hyperhaemolysis in a patient with sickle cell disease: use of steroids and intravenous immunoglobulin to prevent further red cell destruction","volume":"69","author":"Cullis","year":"1995","journal-title":"Vox Sang"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0605","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tmrv.2015.06.001","article-title":"Hyperhemolysis in patients with hemoglobinopathies: a single-center experience and review of the literature","volume":"29","author":"Danaee","year":"2015","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0610","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/trf.12090","article-title":"Immunoglobulin-resistant delayed hemolytic transfusion reaction treated with rituximab in an adult sickle cell patient","volume":"53","author":"Delmonte","year":"2013","journal-title":"Transfusion"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0615","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121631","article-title":"Complement serves as a switch between CD4+ T cell-independent and -dependent RBC antibody responses","volume":"3","author":"Mener","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0620","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3389\/fimmu.2018.00676","article-title":"Complement component 3 negatively regulates antibody response by modulation of red blood cell antigen","volume":"9","author":"Mener","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0625","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/blood-2006-08-040139","article-title":"Mouse models of IgG- and IgM-mediated hemolysis","volume":"109","author":"Schirmer","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0630","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/bloodadvances.2018018408","article-title":"Antibody-mediated immune suppression by antigen modulation is antigen-specific","volume":"2","author":"Maier","year":"2018","journal-title":"Blood Adv"},{"key":"10.1016\/j.tmrv.2019.09.006_bb0635","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/trf.14939","article-title":"Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcgamma receptors in mice","volume":"59","author":"Mener","year":"2019","journal-title":"Transfusion"}],"container-title":["Transfusion Medicine Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796319301348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887796319301348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:18:27Z","timestamp":1760138307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887796319301348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":127,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S0887796319301348"],"URL":"https:\/\/doi.org\/10.1016\/j.tmrv.2019.09.006","relation":{},"ISSN":["0887-7963"],"issn-type":[{"value":"0887-7963","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Examining the Role of Complement in Predicting, Preventing, and Treating Hemolytic Transfusion Reactions","name":"articletitle","label":"Article Title"},{"value":"Transfusion Medicine Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmrv.2019.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}